ruthenium has been researched along with Astrocytoma, Grade IV in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Christou, YA; Dietis, N; Georgiades, SN; Ilmi, R; Odysseos, AD; Pitris, C; Stylianou, P; Tseriotou, E; Ttofi, I | 1 |
| Alves, SR; Colquhoun, A; de Oliveira Silva, D; Wu, XY | 1 |
| Dong, C; Hu, X; Li, R; Lin, Y; Ma, Y; Shi, S; Wu, W; Wu, X | 1 |
| Kulshreshtha, R; Kumar, P; Mondal, I; Patra, AK | 1 |
| Benosman, S; Bischoff, P; Boos, A; Fricker, B; Gaiddon, C; Gross, I; Harlepp, S; Hébraud, P; Jenny, M; Leyva, ML; Loeffler, JP; Meng, X; Pfeffer, M; Sirlin, C; Wlosik, P | 1 |
| Silva, Dde O | 1 |
| Castonguay, A; Doucet, C; Juhas, M; Maysinger, D | 1 |
| Bondareff, W | 1 |
1 review(s) available for ruthenium and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Dimethyl Sulfoxide; Glioblastoma; Humans; Indazoles; Ligands; Neoplasms; Organometallic Compounds; Organoplatinum Compounds; Rats; Ruthenium; Ruthenium Compounds; Solubility | 2010 |
7 other study(ies) available for ruthenium and Astrocytoma, Grade IV
| Article | Year |
|---|---|
A Novel Conjugate of Bis[((4-bromophenyl)amino)quinazoline], a EGFR-TK Ligand, with a Fluorescent Ru(II)-Bipyridine Complex Exhibits Specific Subcellular Localization in Mitochondria.
Topics: Cell Proliferation; Colonic Neoplasms; ErbB Receptors; Extranodal Extension; Fluorescent Dyes; Glioblastoma; Humans; Mitochondria; Protein Kinase Inhibitors; Quinazolines; Ruthenium; Subcellular Fractions | 2019 |
Synthesis of terpolymer-lipid encapsulated diruthenium(II,III)-anti-inflammatory metallodrug nanoparticles to enhance activity against glioblastoma cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Brain Neoplasms; Drug Carriers; Glioblastoma; Humans; Metal Nanoparticles; Ruthenium | 2020 |
[Ru(phen)
Topics: Alkynes; Animals; Antineoplastic Agents; Binding Sites; Cell Proliferation; Cisplatin; Coordination Complexes; DNA, Neoplasm; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Male; Mice; Mice, Nude; Neoplasms, Experimental; Ruthenium; Tumor Cells, Cultured | 2020 |
Development of novel ruthenium(II)-arene complexes displaying potent anticancer effects in glioblastoma cells.
Topics: Antineoplastic Agents; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Glioblastoma; Humans; Ruthenium; Serum Albumin, Human | 2020 |
A ruthenium-containing organometallic compound reduces tumor growth through induction of the endoplasmic reticulum stress gene CHOP.
Topics: Animals; Brain Neoplasms; Cell Division; Cisplatin; Endoplasmic Reticulum; Flow Cytometry; Glioblastoma; Humans; Luciferases; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Organometallic Compounds; Reverse Transcriptase Polymerase Chain Reaction; RNA; Ruthenium; Transcription Factor CHOP | 2009 |
New ruthenium(II)-letrozole complexes as anticancer therapeutics.
Topics: Adenine; Adenocarcinoma; Antineoplastic Agents; Aromatase Inhibitors; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Curcumin; Drug Interactions; Drug Screening Assays, Antitumor; Female; Glioblastoma; Humans; Letrozole; Nitriles; Ruthenium; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2012 |
Submicroscopic distribution of ruthenium red in human glioblastoma multiforme.
Topics: Acetates; Aldehydes; Biopsy; Brain Neoplasms; Cell Membrane; Cell Nucleus; Citrates; Extracellular Space; Glioblastoma; Histological Techniques; Humans; Microscopy, Electron; Mitochondria; Osmium; Ruthenium; Staining and Labeling; Sulfates; Uranium | 1970 |